Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,760.00
(
-0.15%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.43
(
-2.02%
)
Bitcoin
70,438.33
(
-1.13%
)
News Focus
News Focus

Replies to post #72514 on Biotech Values

Replies to #72514 on Biotech Values
icon url

DewDiligence

01/31/09 8:16 PM

#72516 RE: ghmm #72514

BioMS – what does Lilly have to lose to let the trial run to completion?

I’m not sure which trial you’re referring to. The MAESTRO-1 and MAESTRO-3 trials are fully enrolled, so they will run to completion, of course. The MAESTRO-2 trial is an open-label extension that LLY could curtail, but it probably would not save a material amount of money to curtail it.